T he miner's canary, the delicate creature whose death served as an indicator of toxic gases in 19th-century mine shafts, has since become a metaphor for populations of sensitive species whose decline warns of impending threats to the health of humans and other organisms. However, identifying the cause of a population decline is complicated by the presence of multiple environmental hazards and by the complex interactions of a species with its environment (Suter and Barnthouse 1993) . Often causes are assessed only after damage has already occurred (Vasseur and Cossu-Leguille 2003) . Even after identifying a potential threat, it is difficult to establish a connection between the decline of these "canary" species and the risks to human health and to the health of other species in an ecosystem.
The field of genomics-the study of an organism's collection of genes in an attempt to identify genes and to describe the functions they perform, the products they create, and their interactions with one another (Kuska 1998 )-has the potential to address some of these issues. In the past decade, genomics has progressed from labor-intensive identification and study of individual genes to large-scale rapid sequencing and analysis of the entire genome. In addition, tools for genomic analysis have expanded the ability to monitor an organism's physiological response to environmental changes. Whereas researchers were once limited to analyzing single products of gene expression, now they can analyze an organism's global response by simultaneously measuring the expression of thousands of genes at once.
The challenge for many disciplines in the biological sciences is harnessing genomic technologies to advance knowledge in the field (Stearns and Magwene 2003) . In this article, we discuss these technologies and their promise for enhancing one goal of the ecological sciences: the attempt to measure the state of the environment and to link environmental changes with the health of the species within the environment. In addition, we discuss the present challenges and issues surrounding the use of this technology.
Genomics: The new biology toolbox
Genomics as a field has accelerated over the last decade. Through large-scale genome projects (e.g., human, Arabidopsis, fruit fly, nematode), researchers now have information on the genetic composition of several species across the phylogenetic tree. For example, comparisons of rat, mouse, fly, worm, and human gene sequences have provided insight into the genetic basis for disease, development, and behavior as well as information on how a 1% to 2% difference in nucleotides can lead to vast differences between species (e.g., Normile 2001) . The impact of these sequencing efforts reaches far beyond the species whose genomes have been sequenced. Databases of genes and the associated proteins or functional counterparts, not only from these species but from a variety of others, have been developed to provide tools with which to compare genomic information across species (e.g., GenBank, Swiss-Prot) (Altschul et al. 1997) .
Differences that do exist among species are increasingly found to be dependent on how, when, and where genes are expressed. For example, although humans and chimpanzees are genetically very similar, many differences in their brain development and function are caused by differences in gene expression (Normile 2001) . Technologies to measure gene expression are arguably the most influential product of the recent advances in genomics and are revolutionizing other fields as well, including medicine (Sevenet and Cussenot 2003) , toxicology (Hamadeh et al. 2002a) , and evolutionary biology (Gibson 2002, Stearns and Magwene 2003) . These technologies have recently been used to determine the molecular changes associated with muscular dystrophy (Haslett et al. 2002) , the mode of action of many toxins in humans and other species (Waring et al. 2001) , and the gene expression associated with adaptive traits such as plant defenses (MitchellOlds 2001) .
Genomic technologies range from oligonucleotide and complementary DNA microarrays to protein analysis through arrays and mass spectrometry, which aid the study of gene function and changes in physiological states by examining the degree to which genes are expressed as messenger RNA (mRNA) and protein products, respectively. These array expression techniques allow researchers to compare the relative degree of gene expression between two tissues by measuring the transcription of thousands of segments of DNA into mRNA or the subsequent translation into amino acid (protein) sequences. Instead of measuring only the production of a single gene product-one strand of mRNA or the expression of a single protein-they make it possible to identify tens of thousands of mRNAs or proteins, measuring the global response within the tissues of an organism.
The expression profile that is created is relative in that it compares the state of two tissues. These can be two tissues from one organism (e.g., cancerous versus normal tissue), from different species or strains (e.g., brain tissue from chimps versus brain tissue from humans), or, for ecological purposes, from two experimental treatments or samples (e.g., an organism exposed to a toxin versus one that has not been exposed, a plant under drought conditions versus one under a normal watering regime, or a fish in a disturbed stream versus one in a pristine stream). A difference in quantity or type of mRNA or protein measured in one tissue compared with another indicates that gene expression differs between tissues. If two treatments are being compared, this difference indicates that gene expression has increased or decreased in response to a treatment. The profile of relative expression provides researchers with insights into the pathways and systems that are differentially affected by a state change. This information can be used to determine the metabolic pathway with which a gene is associated and to discover the gene's function relative to that pathway.
Microarray experiments measuring mRNA production are relatively inexpensive (especially when compared with studies of individual genes), provide more data, and can be accomplished with or without the complete genomic sequence of the organism. This makes the technology particularly useful for studying a variety of species, not just those that have been chosen for sequencing projects (Crawford 2001) . However, microarray experiments as a whole are limited by design to the qualitative measurement of mRNA production; missing are the steps in which mRNA is spliced and translated into protein sequences. Each of these steps leads to a change in the final protein product from a particular gene. In addition, each gene can code for multiple proteins. Studies are now attempting to make the link between mRNA and the quantity and type of protein production (e.g., Helbing et al. 2003) .
Since proteins are the functional portions of the expressed genome, they may ultimately provide a better indication than mRNA of the effects of perturbations caused by disease, environmental change, or other factors (Fields 2001) . The field of proteomics involves quantifying the protein products of the genome, identifying the forms of these protein products, and determining where they function and how they interact with other proteins (Fields 2001) . Researchers can construct protein arrays similar to the microarrays that measure mRNA. In this process, antibodies or other molecules that bind to a specific protein or set of proteins are spotted onto a platform, making it possible for proteins that have similar binding properties to be investigated for similar function. Like the microarrays for mRNA, this method allows thousands of samples to be assayed at once, unlike traditional methods of extracting and examining one protein at a time. Separation methods and the structural identification process for proteins have also advanced through improved mass spectrometry technologies, which now allow for the separation and analysis of hundreds of proteins at once.
Changes in gene expression, from mRNA to protein production, provide information about how an organism responds to a given environmental insult. These changes are ultimately manifested, however, in actual alterations of systems and metabolic pathways. The field of metabonomics measures these changes in an individual, using nuclear magnetic resonance imaging techniques (Shockcor and Holmes 2002) . For example, nuclear magnetic resonance imaging can be used to examine multiple metabolites within living tissue or to observe how bodily fluids change with environmental changes. In figure 1 , the metabolites found in muscle, digestive glands, and hemolymph differ between healthy abalone and those that are stunted with unknown disease or affected by withering syndrome (Viant et al. 2003) .
Because of the quantity of data generated by these methods, extracting meaningful insights is a nontrivial exercise (Knudsen 2002) . For example, more than 2000 genes are involved in stress responses in plants (Kreps et al. 2002) . Furthermore, because of the sensitivity of the techniques, slight variations in protocols can introduce larger variations in gene expression measurements. Individuals within a species can also vary in gene expression (Oleksiak et al. 2002) . This has led many authors to point out the unreliability or uncertainty of the data from these techniques (Brazma et al. 2001 , Li et al. 2002 . However, many studies are focusing on the development of standardized laboratory and analysis procedures to increase the accuracy of comparisons among different laboratories (Brazma et al. 2001 , Li et al. 2002 , Quackenbush 2003 . In addition, validation with other techniques confirms the expression pattern and the magnitude of expression more than 90% of the time (Quackenbush 2003) . Researchers are adjusting statistical analysis and experimental design to reduce error and even taking advantage of the variation within a species to investigate how individual variation plays a role in physiology.
It is important to note that changes in gene expression alone are not necessarily indicative of end points such as toxicity or stress. Even what seems like a benign activity, such as eating, sleeping, or moving from one temperature to another, can cause changes in gene expression. Changes in levels of mRNA, proteins, or metabolites may also be nonspecific indicators of exposure to stress without ties to a specific negative outcome. Gene expression could indicate that an organism is adapting to its changing environment without an adverse consequence. To be a meaningful indicator of an adverse response, expression must be linked both to information on the pathways that have been altered and to the overall phenotypic effects observed.
Genomics as a better "canary" for the state of the environment To protect human health and the health of the natural environment, various government, nonprofit, and academic organizations monitor changes in US ecosystems over time with respect to various possible stressors. Stressors include changes in habitat or land use; introduction of pesticides, pharmaceuticals, bacteria, or fertilizers; temperature changes or global warming; and natural environmental fluctuations.
Although researchers have the means to measure changes in many of these physical factors within the environment, merely measuring the presence of a stressor or an environmental change is not enough. A chemical, for instance, may need to be of a high concentration, to be ingested and reach a tissue where it is reactive, and to occur during a certain life stage of the organism to have a critical effect. To determine the actual health of a species or the overall health of an environment, it is important to measure the actual biology of the physiological and population status of species within the environment.
Given the impossibility of determining the status of every organism and every function in an ecosystem, current environmental health assessments rely on certain other measurements as surrogates. These indicators include changes in ecosystem measurements (respiration, photosynthesis, energy flow), community measurements (biodiversity, species richness, population numbers), and physiological measurements within a species of interest (mRNA or protein produced in individuals within a population in response to an environmental stressor) (Heinz Center 2002 , EPA 2003 .
For example, the induction of the protein metallothionein in an organism is an indicator that the organism has been exposed to and is attempting to deal with exposure to heavy metals (LeBlanc and Bain 1997). A change in the composition of a stream community from a relatively species-rich environment to one where only resilient species survive is a sign of a disturbance (Suter and Barnthouse 1993) . Similarly, changes in levels of respiration or photosynthesis in an ecosystem can indicate a shift in microbial community structure due to a disturbance. Ideally, all of these indicators would be linked to show how changes in the physiological measurements of a species relate to overall population numbers and how those numbers, in turn, affect ecosystem function (and ultimately what that means about the health of the environment), but there are few examples in which this link has been made.
The recent Draft Report on the Environment released by the US Environmental Protection Agency (EPA 2003) defines several issues that arise in current efforts to monitor the health of the environment and humans within the environment. These include, but are not limited to, the following:
• Exposure to stressors in the field is often at very low but chronic levels, and detection of exposure is difficult. Links need to be made between low-level stressors and effects, and tools need to be developed that provide an early warning of those effects. It is also important to identify the level of exposure or dose needed to cause an effect.
• There are multiple potential stressors in any environment, and effects can be a result of chronic low-level exposure to multiple stressors. It is difficult to separate the effects from each stressor and to know whether these factors act synergistically within an organism. Current monitoring techniques, such as measuring chemical concentrations in tissues and using single biomarkers of exposure or effect, are limited in that they are not able to distinguish among different pollutants or stressors.
• Measurements are often retrospective, in that a change in the biota is observed (e.g., a change in primary productivity, a drop in the number of eagles, or an increase in lung cancer in humans) and only afterward is there an attempt to find the cause. An early indicator that provides real-time information on the status of species and communities within the environment is needed.
• Indicators of ecological status need to be linked to a greater model that takes multiple stressors into account, along with the various responses of the diverse species that make up the ecosystem. To do this, researchers need to develop a technique that can link the effects seen in multiple organisms more closely than the methods that are currently available.
Genomic indicators of low levels of exposure and early effects
Gene expression, in the form of mRNA or proteins, has been shown to be an early indicator of physiological problems that are not yet phenotypically visible. For example, mRNA and protein markers are used to determine the earliest stages of breast and ovarian cancer, which are often asymptomatic and difficult to detect (Wooster and Weber 2003) . These technologies can also be used as early indicators of problems in nonhuman species. Changes in gene expression occur well in advance of reproductive or morphological problems and can be detected after small environmental changes; therefore, they could be used as early indicators of negative environmental effects. Xenopus tadpoles exposed to more than 10 parts per million (ppm) of Aroclor 1254, a common PCB (polychlorinated biphenyl), develop abnormal tail morphology (figure 2) and behavioral problems and die from exposure, whereas those exposed to a much lower dose of 1 ppm show no immediate phenotypic response (Jelaso et al. 2002) . However, eventually a great number of these tadpoles also die (figure 3; Jelaso et al. 2002) . Several genes involved in neurological and metabolic functions whose expression is reduced by the higher doses also show decreased expression at the 1-ppm dose (figure 4). These changes in gene expression occur well in advance of structural problems and mortality. Since they are linked to genes with functions relevant to the morphological changes observed, they provide an early indication of impending problems. Data on gene expression also provide information as to the health of a species or how a stressor or environmental change affects it. By identifying the genes that are differentially expressed and their associated physiological pathways, researchers can identify which physiological systems are being disrupted or changed in response to environmental stressors. In the example above, changes in genes affecting morphology and neurological development provide an indication of which systems are affected when a tadpole is exposed to Aroclor 1254. This technique is being applied to toxicology to look at the mode of action of various chemicals that have been released into the environment (Pennie 2000 , Hamadeh et al. 2002b ). As more data on genomics become available for species of ecological interest, changes in the expression of genes associated with physiological or reproductive problems could serve as an early warning of impending environmental problems in a larger community of species, including those outside the standard laboratory models.
Separating exposure and effects of multiple stressors
Within an organism, different forms of the same protein are produced to deal with compounds that are of the same structural group but not identical (Clark et al. 1986 ). These proteins can be used to identify separate exposures to different chemicals in the field and any effects manifested from these exposures (Stegeman et al. 1992) . Genomics advances this technique by providing not just a single compound as an indicator but a profile of hundreds of proteins or genes that have been upregulated or downregulated in response to a stimulus, providing a unique and specific profile of an organism's response. Profiles can be used to differentiate exposure to a variety of compounds with different modes of action in addition to compounds that belong to the same chemical class (Bartosiewicz et al. 2001 , Waring et al. 2001 , Hamadeh et al. 2002a , 2002b . For example, rat livers exposed to compounds with different modes of action produce different mRNA groups, providing a distinct profile for each chemical class of compounds and for each compound within a class (Hamadeh et al. 2002b ). In addition, a portion of the genes expressed are transient and a portion are delayed, providing a method for monitoring time and duration of exposure as well as adaptations to exposure within an organism (Hamadeh et al. 2002b) . Gene expression profiles of human lung cells that have been treated with cadmium, chromium, or nickel show some overlap in gene expression, but they also show a large number of genes that are unique to each type of exposure (figure 5). Expression profiles extend beyond toxicology studies to general physiological responses to stressors. Salt, cold, and osmotic stress in Arabidopsis induce common stress response genes; however, each stressor also induces the production of a number of unique mRNAs, creating a distinct profile (Kreps et al. 2002) . The number of overlapping responses decreases over time, creating a greater distinction between the unique identification profiles of the different stressors.
The genes that are expressed and the direction of their expression can also change with respect to level of exposure (Andrew et al. 2003 , Jelaso et al. 2003 , providing insight into the ways in which an organism attempts to cope with an insult. For example, human lung tissue exposed to 5-micromolar (µM) concentrations of arsenic, which shows no significant cytotoxicity, has a different gene expression profile from that of tissue exposed to 50-µM concentrations, which is highly toxic (figure 6). Only 16 of 158 genes had differential expression at both doses. In tissue exposed to the higher dose, genes were only upregulated; at the lower dose, by contrast, they showed a variable response. However, more total genes responded to the lower dose. The key to interpreting this response is identifying the genes. The response at lower doses may be an initial stress response, or it may be the result of an attempt by the organism to adapt to the stressor, followed by major metabolic changes as the level of exposure increases. Establishing a database of expression profiles for known compounds, diseases, and environmental conditions will provide a robust means of identifying exposure to unknown stressors. The National Institute of Environmental Health Sciences (Waters et al. 2003) and several academic institutions (Mattingly et al. 2003) are in the process of developing databases supporting links among genes, proteins, stressors, and traditional toxicological end points across various species used by the toxicology community. If these databases extended beyond toxicology to include other relevant ecological stressors, to supply information about the environment each species was in at the time of measurement (including information about location of sampling), and to contain information on species relevant to environmental monitoring efforts, they could provide the tools needed to separate the causes of species declines identified in ecological monitoring efforts.
Current monitoring versus retrospective measurement
It is often difficult to determine what factors are causing the decline in a population. Ultimately, the creation of a database of stressors and their respective gene and protein expression profiles should make it possible to use this information outside the laboratory as a tool to more immediately identify problems within a population. Genomic technologies will be a direct means to identify the types of stressors to which an organism is exposed and to differentiate among the effects of various environmental factors that affect a population. The early changes in gene expression that occur in response to environmental stimuli, and the specificity of these responses, provide data about the immediate response of a species before a population decline. The development of tests specific to a particular population, examining changes in the gene expression of native species, could provide an indication of exactly what an organism may have been exposed to and a way of monitoring the effects of various compounds at low doses before these effects are visible in the natural population.
As an example, various pesticides and pharmaceutical compounds, when released into the environment, have been found to disrupt the endocrine systems of many native species and to decrease the reproductive capabilities of exposed organisms. These effects have been difficult to document in natural populations. Using genomic applications, researchers can study the exact pathways that have been disrupted and the mechanism of action of each compound. In fish, exposure to these compounds causes a change in the gross morphology of the female, a decrease in overall egg production and viability, and ultimately a decrease in fecundity. These endocrine disrupting compounds (EDCs) increase the levels of vitellogenin and choriogenin proteins in male fish and cause morphological changes in their sexual characteristics. In the fathead minnow, Pimephales promelas, EDCs have been linked to detrimental changes in eggs developing within the female fish and to a decrease in overall reproductive success. Levels of vitellogenin have been used as a biomarker or protein marker to detect EDC exposure. Now genomic tools are being developed in conjunction with vitellogenin assays (Lattier et al. 2001) . A macroarray chip for the sheepshead minnow (Cyprinodon variegatus), a native of the Gulf of Mexico, has been developed to identify gene expression signals of vitellogenin pathway interference as an indicator of exposure to EDCs in the field (Larkin et al. 2002) .
Molecular markers from blood or tissue in an ecological sample could aid in monitoring threatened or endangered species, replacing more destructive sampling techniques. Samples of blood and tissue contain many markers that are currently used in medical research. Plasma proteins, for example, have been used as a basis for human disease diagnostics, and the number of known protein markers is increasing exponentially because of advances in proteomics (Anderson and Anderson 2002) . In humans, more than 300 plasma proteins have been identified to date, including proteins from not only blood but also tissues. These are sensitive markers and can differ by 10 orders of magnitude with various physiological states (Anderson and Anderson 2002) . Plasma markers based on mRNA, or on hundreds more proteins than those used in current single biomarker studies, could be developed for fish or other vertebrates to indicate exposure events or physiological problems that lead to population decline.
One possible drawback to these techniques may be the variability caused by other environmental conditions. Organisms are exposed to greater variation in environmental factors in situ than in the laboratory, and this variation can have an effect on gene or protein expression. Therefore, researchers will need to identify genomic responses that are consistent between the laboratory and the natural environment. Another potential difficulty is that some environmental factors affecting populations are of short duration, and the changes in gene expression patterns in response to these factors may last for only a short period of time. Protein profiles may be the best approach here, as they provide a longer-lasting signal than mRNA in response to change. Clearly, methods will need to be developed to apply the appropriate tools to field situations.
Using genomics to develop a complex model of the state of the environment
One of the most important developments from research in genomics will be the capability to directly compare the physiological responses of different species. Conserved pathways among phyla provide a basis for using well-studied model species to study species of concern (Crawford 2001) . For example, molecular data indicate that at least 17 signal transduction pathways involved in development and differentiation are highly conserved among several model organisms, including yeast (Saccharomyces cerevisiae), fruit flies (Drosophila spp.), zebrafish (Danio rerio), and roundworms (Caenorhabditis elegans) (NRC 2000) . The greater the similarity in molecular function among species, the greater the ability to relate changes in one organism to changes in another. In this way, genomic data could eventually be used to link health-related changes in gene expression in other species to similar changes in humans and thus to provide a connection between human health and the health of other species.
Although there are striking similarities across taxa, there are also many differences. Humans, mice (Mus musculus), chickens (Gallus domesticus), green anoles (Anolis carolinensis), and rainbow trout (Oncorhynchus mykiss) have significant differences in their genetic codes for hormonal receptors. These differences affect the binding of various environmental toxins that disrupt developmental pathways (Matthews et al. 2000) .
Variation also exists within a species, and genomic technologies provide a mechanism to examine change in gene function with a genetic modification. Slight variations within a gene can have significant results for the subset of individuals within a population with that modification. Genetic polymorphisms for several detoxification enzymes in humans, for example, have been shown to modify the poisoning effects of benzene (Wan et al. 2002) . In the past, identifying these polymorphisms was a very labor-intensive process involving single-gene evaluations. Now, using microarrays and proteomic technologies, hundreds of gene products from hundreds of individuals can be tested to identify variations more rapidly. The current focus of much of the Human Genome Project is on identifying these polymorphisms in humans in relation to disease and susceptibility. In terms of environmental monitoring, this could mean identifying how current measurements of genetic variation relate to population sustainability.
Linking genomics to current monitoring programs
Genomics as an indicator will be most useful if it is placed in the context of current monitoring efforts, such as the US Geological Survey's National Water-Quality Assessment (NAWQA) program, the EPA's Environmental Monitoring and Assessment Program (EMAP), and the National Science Foundation's proposed National Ecological Observatory Network (NEON). NAWQA monitors 50 river basins and aquifers for different measures of water quality over time, including water chemistry, hydrology, stream habitat, and aquatic life (USGS 2001) . This activity also supports EMAP, which was designed to monitor and protect the freshwater resources of the United States. Current ecological risk assessments in these programs include creating a database of baseline information about the physical and biological aspects of these aquatic systems over time and monitoring changes in the relationship of pollutants, natural variation, and land-use changes within watersheds.
When a population of indicator species within the watershed declines, researchers attempt to correlate the decline with other measures that occurred in a similar time period. However, as mentioned previously, many pollutants that affect indicators occur at low doses and originate from large land scales rather than small point sources, making exposure and its effects difficult to measure. Furthermore, several of the factors that affect populations are correlated, and it is often difficult to determine which factor actually has the largest impact on a population. For example, increases in sediments that wash into streams after a heavy rainfall are correlated with increases in pesticide runoff, changes in water temperature, and increases in bacterial loads (from runoff over impervious surfaces and sewage overflows). Any of these factors could contribute to a change in habitat conditions for an aquatic indicator such as a fish or an insect larvae. Genomic methods are sensitive, provide early detection, permit comparison among species, and, instead of destructively sampling an entire community, allow researchers to extract samples of blood or tissue from indicator species and analyze them for changes in gene expression in the form of mRNA or protein, indicating the health of the organism and the potential factors that could cause a population decline. Since the gene expression profiles are specific to certain environmental exposures (Hamadeh et al. 2002a (Hamadeh et al. , 2002b NAWQA, EMAP, and NEON are all developing genomic methods for certain aspects of their programs, but not necessarily for the purposes mentioned above. EMAP is developing genomics technologies to identify the types of bacteria and the quantity of harmful bacteria in a freshwater sample by measuring gene expression products that are characteristic in the bacteria of interest. NEON has proposed using comparative genomics to determine why some species become invasive when others do not. However, genomics could become even more significant in these programs by extending monitoring capabilities and by providing a new, early measure of the condition of organisms or populations.
Current limitations, problems, and research needs
Genomic research has previously seemed inapplicable in many ecological contexts because of the lack of data on species of interest and the costs associated with the technology. The focus on species that are models for human health, agricultural species, and disease organisms does limit the potential ecological applications of genomic technologies. However, within the next decade, it is estimated that projects the size of the Human Genome Project will cost less than $10,000 and will take only a few hours to complete (Hood 2001) . This projected reduction in the time and expense of genomics research will extend the availability of the current technology to the study of a diversity of species.
Without a complete sequence, information can also be derived using comparative sequence information from model species (Crawford 2001, Ramarathnam and Subramaniam 2000) . However, in targeting systems and pathways that are differentially expressed, microarray experiments without genome sequence data are restricted to those systems or pathways that have comparative sequences in model organisms.
One of the other drawbacks to using organisms whose genomes are not fully sequenced is the variation among microarray results from various laboratories, caused by the use of different segments of genetic material in microarray construction. With a complete sequence, standardized microarray chips can be created using known gene sequences, increasing the consistency among experiments.
Several scientific issues have arisen surrounding genomic technology; these need to be addressed so the technique can be used properly and consistently, without causing an unnecessary scare or raising doubt about reliability. Standards need to be developed for array creation, RNA isolation and hybridization, and data analysis in order for these techniques to provide consistent and useful results (Li et al. 2002) . Variability among individuals creates a problem for standardization of response: What will be the baseline gene expression used for comparisons? Nonetheless, this variation may also provide insight as to how differences within a population affect the response to an environmental change. Singlenucleotide polymorphisms in humans have already been shown to affect susceptibility to toxins and disease (Pennie 2000) . Variation in expression also occurs with developmental stage (Jelaso et al. 2003) . This variation makes standardization difficult, especially with regard to field sampling, but ultimately it also provides invaluable information as to which stage is the most sensitive to various environmental insults.
Other issues will have to be addressed to take this technology to the field. As mentioned previously, gene expression will need to be tied to metabolic changes and ultimately to an adverse outcome to be useful as a predictor. Gene expression in the form of mRNA may be too sensitive a measure in some cases, or too fleeting. There may be a long time between an mRNA response and a protein response, and then between the protein response and an adverse physiological outcome. RNA may provide only a snapshot of the response at one time within one tissue, and toxicity develops most often as a result of exposure over a longer period of time (Neumann and Galvez 2002) . As a result, questions will arise as to when a measurement should be taken and how much of a change needs to occur for the genomic indicator to serve as a predictor of future damage. The changes in gene expression will also need to be measurable over other environmental "noise," such as changes in temperature and food.
Genomic techniques will not completely replace other measures of environmental condition, but they could reduce the amount of destructive sampling needed, complement existing community measurements, lessen the amount of labor and testing required for toxicology studies, and provide an earlier warning of ecosystem stress and decline. The data will also provide a basis for asking other ecological and evolutionary questions. Genomic and proteomic technologies add a new dimension to the tools currently available for ecological risk assessment through traditional toxicology and ecology. Greater support, both financial and organizational, for genomic studies on ecologically relevant organisms will advance this technology to applications beyond human health and agricultural improvement. By providing rapid results with relatively little expense, microarray technologies will open the door to a new understanding of ecological phenomena and disturbances.
